Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2017-12-01
2023-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Evaluation of the LithoVue Elite Ureteroscope
NCT04900688
Comparing Treatment of Urolithiasis Between Disposable and Reusable Ureteroscope
NCT03040466
Evaluation of Novel Disposable Flexible Ureteroscope for the Treatment of Renal Calculi
NCT05646069
Use of a Ureteral Access Sheath During Ureteroscopy and Its Effect on Stone Free Rate
NCT00199524
To Evaluate the Safety and Efficacy of LithoVue Ureteroscope System in Chinese Patients With Urinary Disease
NCT03676972
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Reusable Ureteroscope
Standard ureteroscope.
Reusable Ureteroscope
Comparative device.
single-use flexible digital ureteroscope (LithoVue)
Disposable ureteroscope being tested.
single-use flexible digital ureteroscope
Device being tested.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
single-use flexible digital ureteroscope
Device being tested.
Reusable Ureteroscope
Comparative device.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 19 years or older and able to provide informed consent
Exclusion Criteria
* pregnant
* patients with known nephrocalcinosis .
* any other reason that in the opinion of the investigator would make the participant unsuitable for enrollment in the study.
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston Scientific Corporation
INDUSTRY
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ben Chew, MD
Associate Professor of Urology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ben H Chew, MD
Role: PRINCIPAL_INVESTIGATOR
University of British Columbia, Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eye and Ear Institute - Department of Urology
Columbus, Ohio, United States
University of British Columbia
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H16-02436
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.